V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190009365 | 190006980 | 0 | 53.8 | null | 2015-08-18 | 2015-09-21 | OST Rel Ifosfamide Etoposide | 02 | N | CYCLOPHOSPHAMIDE + ETOPOSIDE | 101285967 |
| 190009370 | 190006981 | 0 | 64.5 | Curative (C) | 2018-08-21 | 2018-08-25 | EW Rel rEECur Gemcitabine/Docetaxel | null | null | CYTARABINE + FLUDARABINE | 100310839 |
| 190009375 | 190006982 | 0 | 88 | Curative (C) | 2021-04-26 | 2021-04-26 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 101571506 |
| 190009383 | 190006983 | 1.63 | 80.3 | Palliative (P) | 2021-04-20 | 2021-11-17 | EW EuroEwing 2012 Arm B IE | 02 | Y | EW EUROEWING 2012 ARM B IE | 101263645 |
| 190009391 | 190006984 | 0 | 59.8 | Palliative (P) | 2021-01-29 | 2021-05-08 | NIVOLUMAB | 02 | N | DOCETAXEL | 100856565 |
| 190009394 | 190006985 | 0 | 49.3 | Palliative (P) | 2020-03-23 | 2020-03-30 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 101428911 |
| 190009396 | 190006986 | 0 | 59.4 | Neo-adjuvant (N) | 2019-02-06 | 2019-06-26 | Etoposide + Ifosfamide (3 days) | 01 | null | ETOPOSIDE + IFOSFAMIDE | 101470043 |
| 190009397 | 190006987 | 0 | 36 | null | 2016-10-13 | 2016-12-12 | Etoposide + Ifosfamide (3 days) | null | null | ETOPOSIDE + IFOSFAMIDE | 100097636 |
| 190009405 | 190006988 | 1.6 | 58 | null | 2019-04-26 | 2019-05-12 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101728198 |
| 190009408 | 190006989 | 1.13 | 104.2 | Curative (C) | 2021-06-26 | 2021-06-26 | EW Rel rEECur Irinotecan/Temozolomide | 02 | N | CISPLATIN | 100768830 |
| 190009415 | 190006990 | 1.85 | null | Palliative (P) | 2019-09-06 | 2019-09-15 | Oxaliplatin + Modified de Gramont | 01 | N | GEMCITABINE + OXALIPLATIN | 100285785 |
| 190009428 | 190006992 | 0 | 27.6 | null | 2022-01-16 | 2022-01-24 | DOXORUBICIN | N | N | DOXORUBICIN | 101159450 |
| 190009436 | 190006993 | null | 58.7 | null | 2019-02-28 | 2019-04-17 | ETOPOSIDE + IFOSFAMIDE + MESNA | null | null | ETOPOSIDE + IFOSFAMIDE | 101506781 |
| 190009440 | 190006994 | 0 | 50.3 | Palliative (P) | 2018-06-27 | 2018-07-04 | Methotrexate High Dose (3g/m2) | null | null | METHOTREXATE | 100102281 |
| 190009449 | 190006995 | 1.79 | 40 | Curative (C) | 2020-09-29 | 2020-12-27 | VAI (Ifos 3g/m2) | 99 | null | IMATINIB | 101848028 |
| 190009459 | 190006996 | 1.52 | 26.5 | Palliative (P) | 2018-07-30 | 2018-08-08 | BUSULFAN + MELPHALAN | 02 | N | EW EUROEWING 2012 ARM A VAI | 101373999 |
| 190009469 | 190006997 | 0 | 29.2 | Neo-adjuvant (N) | 2018-08-21 | 2018-09-16 | PAM x 2 post-surgery (cycles 3&4) | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 100346219 |
| 190009473 | 190006998 | 1.8 | 44.8 | Palliative (P) | 2020-09-10 | 2020-10-10 | Doxorubicin + Ifosfamide | 02 | null | OST AP | 100708468 |
| 190009503 | 190007000 | 1.11 | 76.9 | Neo-adjuvant (N) | 2019-12-27 | 2020-03-03 | Doxorubicin 75mg/m2 | 01 | N | DOXORUBICIN | 100485177 |
| 190009505 | 190007001 | 1.67 | 58.7 | Curative (C) | 2018-10-20 | 2018-11-13 | null | 02 | Y | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 100154257 |
| 190009511 | 190007002 | 0 | 69.1 | null | 2018-06-27 | 2018-07-31 | Hydroxycarbamide | N | N | MAP | 101066893 |
| 190009512 | 190007003 | 1.77 | 92 | Palliative (P) | 2018-01-23 | 2018-07-11 | DHAP | null | null | EURO-EWING | 101738123 |
| 190009516 | 190007004 | 0 | 18.3 | Curative (C) | 2021-09-27 | 2021-09-27 | OST Euramos 1 Closed Trial - M | 02 | null | OST M | 101835370 |
| 190009522 | 190007005 | 0 | 0 | Adjuvant (A) | 2020-07-27 | 2020-07-30 | MAP | 02 | N | CISPLATIN + DOXORUBICIN + METHOTREXATE | 101045682 |
| 190009532 | 190007006 | 1.74 | 64.6 | Palliative (P) | 2016-04-20 | 2016-10-12 | Trial Unspecified | 2 | null | TRIAL UNSPECIFIED | 100808837 |
| 190009534 | 190007007 | 0 | 8.9 | Palliative (P) | 2020-01-03 | 2020-01-08 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100158036 |
| 190009544 | 190007008 | 1.9 | 53.2 | Palliative (P) | 2019-10-29 | 2019-11-03 | Carboplatin + Cetux + FU (>Cycle 2) | 01 | N | VAI | 100979755 |
| 190009548 | 190007009 | 0 | 72.6 | Curative (C) | 2016-07-15 | 2016-12-08 | ETOPOSIDE + IFOSFAMIDE | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100759437 |
| 190009561 | 190007010 | 0 | 47 | Adjuvant (A) | 2021-04-20 | 2021-07-04 | CARBOPLATIN + FLUOROURACIL | 02 | N | EW EUROEWING 2012 ARM A VAI | 101277746 |
| 190009566 | 190007011 | 1.53 | 107.9 | Curative (C) | 2019-05-24 | 2019-10-24 | GEMCARBO | null | null | NB HRNBL-1 COJEC IND COURSE B | 100417776 |
| 190009570 | 190007012 | 0 | 21 | Neo-adjuvant (N) | 2021-05-09 | 2021-06-08 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100245391 |
| 190009576 | 190007013 | 1.79 | 62 | Curative (C) | 2017-10-08 | 2018-05-16 | Etoposide oral | 02 | N | EW EUROEWING 2012 ARM A VAI | 101692741 |
| 190009580 | 190007014 | 1.64 | 63 | null | 2019-01-01 | 2019-02-13 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101149101 |
| 190009586 | 190007015 | 1.7 | 44 | null | null | 2020-04-05 | EW EuroEwing 2012 Arm B VC | 02 | null | EW EUROEWING 2012 ARM B VC | 100381543 |
| 190009605 | 190007016 | 0 | 25.4 | null | 2016-08-24 | 2016-10-06 | Cyclophosphamide + Topotecan | null | null | CISPLATIN + DOXORUBICIN + METHOTREXATE + MIFAMURTIDE | 101617699 |
| 190009610 | 190007017 | 1.71 | 103.8 | Curative (C) | 2019-02-24 | 2019-03-01 | Etoposide + Ifosfamide (3 days) | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100120986 |
| 190009614 | 190007018 | 0 | 28.8 | Curative (C) | 2018-02-01 | 2018-02-07 | Irinotecan + Modified De Gramont | 02 | N | DOXORUBICIN + METHOTREXATE | 100647864 |
| 190009619 | 190007019 | 1.76 | 47.8 | Neo-adjuvant (N) | 2019-10-21 | 2019-11-05 | OST Euramos 1 Closed Trial - M | 02 | N | MAP | 100675442 |
| 190009636 | 190007020 | 0 | 11.8 | Neo-adjuvant (N) | 2020-08-07 | 2020-08-20 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 100342245 |
| 190009650 | 190007021 | 1.28 | 49 | null | 2019-05-26 | 2019-05-30 | DOCETAXEL + GEMCITABINE | 02 | N | DOCETAXEL + GEMCITABINE | 101732192 |
| 190009651 | 190007022 | 0 | 43.4 | Palliative (P) | 2017-02-16 | 2017-02-16 | EW EuroEwing 2012 Arm B VC | 02 | N | EW EUROEWING 2012 ARM B VC | 101343658 |
| 190009668 | 190007023 | 1.7 | 55.4 | Palliative (P) | 2019-10-25 | 2020-02-24 | EW EuroEwing 2012 Arm A VAC | 02 | null | EW EUROEWING 2012 ARM A/B ZOL ACID | 100473939 |
| 190009699 | 190007024 | 1.68 | 84.1 | Palliative (P) | 2014-10-12 | 2016-06-18 | Gemcitabine weekly | 02 | N | EW REL REECUR TOPOTECAN/CYCLOPHOSPHAMIDE | 101276424 |
| 190009714 | 190007025 | 1.88 | 36 | null | 2020-11-20 | 2020-11-30 | NIVOLUMAB | 02 | N | CYCLOPHOSPHAMIDE + VINCRISTINE | 100693857 |
| 190009726 | 190007026 | 1.55 | 65.9 | Curative (C) | 2017-02-16 | 2017-06-22 | EW EuroEwing 2012 Arm A VIDE | N | N | CAV | 100301166 |
| 190009733 | 190007027 | 1.79 | 88 | null | 2017-02-06 | 2017-06-18 | EW EuroEwing 99 : VIDE | 02 | null | CISPLATIN + DOXORUBICIN | 101188031 |
| 190009744 | 190007028 | 1.6 | 78 | Palliative (P) | null | 2016-07-01 | Trial Unspecified | 02 | null | EURO-EWING | 100054242 |
| 190009746 | 190007029 | 1.7 | 102.4 | Curative (C) | 2021-09-09 | 2021-09-13 | EW Rel rEECur Topotecan/Cyclophosphamide | 02 | N | NB HRNBL-1 COJEC IND COURSE A | 100319042 |
| 190009759 | 190007030 | 1.84 | 101.6 | null | 2020-06-25 | 2020-10-12 | EW EuroEwing 2012 Arm B IE | 02 | null | EW EUROEWING 2012 ARM B IE | 100644042 |
| 190009761 | 190007031 | 1.63 | 76 | Palliative (P) | 2018-03-26 | 2018-04-06 | CAPECITABINE + CARBOPLATIN | N | N | CETUXIMAB + IRINOTECAN + MDG | 100077199 |